Literature DB >> 12760897

Mechanism of action of 4-phenoxyphenoxyethyl thiocyanate (WC-9) against Trypanosoma cruzi, the causative agent of Chagas' disease.

Julio A Urbina1, Juan Luis Concepcion, Andrea Montalvetti, Juan B Rodriguez, Roberto Docampo.   

Abstract

We investigated the molecular basis of the activity of 4-phenoxyphenoxyethyl thiocyanate (WC-9) against Trypanosoma cruzi, the etiological agent of Chagas' disease. We found that growth inhibition of T. cruzi epimastigotes induced by this compound was associated with a reduction in the content of the parasite's endogenous sterols due to a specific blockade of their de novo synthesis at the level of squalene synthase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12760897      PMCID: PMC155860          DOI: 10.1128/AAC.47.6.2047-2050.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

Review 1.  Recent developments in the chemotherapy of Chagas disease.

Authors:  R Docampo
Journal:  Curr Pharm Des       Date:  2001-08       Impact factor: 3.116

2.  Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana.

Authors:  Julio A Urbina; Juan Luis Concepcion; Salomé Rangel; Gonzalo Visbal; Renee Lira
Journal:  Mol Biochem Parasitol       Date:  2002 Nov-Dec       Impact factor: 1.759

3.  Bisphosphonates are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase.

Authors:  A Montalvetti; B N Bailey; M B Martin; G W Severin; E Oldfield; R Docampo
Journal:  J Biol Chem       Date:  2001-07-02       Impact factor: 5.157

4.  Squalene synthase: steady-state, pre-steady-state, and isotope-trapping studies.

Authors:  E S Radisky; C D Poulter
Journal:  Biochemistry       Date:  2000-02-22       Impact factor: 3.162

Review 5.  Chemotherapy of Chagas disease.

Authors:  Julio A Urbina
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

Review 6.  Specific treatment of Chagas disease: current status and new developments.

Authors:  J A Urbina
Journal:  Curr Opin Infect Dis       Date:  2001-12       Impact factor: 4.915

7.  Recombinant squalene synthase. A mechanism for the rearrangement of presqualene diphosphate to squalene.

Authors:  Brian S J Blagg; Michael B Jarstfer; Daniel H Rogers; C Dale Poulter
Journal:  J Am Chem Soc       Date:  2002-07-31       Impact factor: 15.419

8.  Recombinant squalene synthase. Synthesis of non-head-to-tail isoprenoids in the absence of NADPH.

Authors:  Michael B Jarstfer; Dong-Lu Zhang; C Dale Poulter
Journal:  J Am Chem Soc       Date:  2002-07-31       Impact factor: 15.419

9.  Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.

Authors:  J A Urbina; G Payares; L M Contreras; A Liendo; C Sanoja; J Molina; M Piras; R Piras; N Perez; P Wincker; D Loebenberg
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

10.  Design, synthesis, and biological evaluation of aryloxyethyl thiocyanate derivatives against Trypanosoma cruzi.

Authors:  Eleonora Elhalem; Brian N Bailey; Roberto Docampo; István Ujváry; Sergio H Szajnman; Juan B Rodriguez
Journal:  J Med Chem       Date:  2002-08-29       Impact factor: 7.446

View more
  14 in total

1.  Synthesis and biological evaluation of new 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase.

Authors:  Valeria S Rosso; Sergio H Szajnman; Leena Malayil; Melina Galizzi; Silvia N J Moreno; Roberto Docampo; Juan B Rodriguez
Journal:  Bioorg Med Chem       Date:  2011-04-01       Impact factor: 3.641

2.  In Vitro and In Vivo Activities of Sulfur-Containing Linear Bisphosphonates against Apicomplexan Parasites.

Authors:  Sergio H Szajnman; Tamila Galaka; Zhu-Hong Li; Catherine Li; Nathan M Howell; María N Chao; Boris Striepen; Vasant Muralidharan; Silvia N J Moreno; Juan B Rodriguez
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

3.  Activity of Fluorine-Containing Analogues of WC-9 and Structurally Related Analogues against Two Intracellular Parasites: Trypanosoma cruzi and Toxoplasma gondii.

Authors:  María N Chao; Catherine Li; Melissa Storey; Bruno N Falcone; Sergio H Szajnman; Sergio M Bonesi; Roberto Docampo; Silvia N J Moreno; Juan B Rodriguez
Journal:  ChemMedChem       Date:  2016-11-25       Impact factor: 3.466

4.  Head-to-head prenyl tranferases: anti-infective drug targets.

Authors:  Fu-Yang Lin; Yi-Liang Liu; Kai Li; Rong Cao; Wei Zhu; Jordan Axelson; Ran Pang; Eric Oldfield
Journal:  J Med Chem       Date:  2012-05-01       Impact factor: 7.446

5.  Aryloxyethyl Thiocyanates Are Potent Growth Inhibitors of Trypanosoma cruzi and Toxoplasma gondii.

Authors:  María N Chao; Carolina Exeni Matiuzzi; Melissa Storey; Catherine Li; Sergio H Szajnman; Roberto Docampo; Silvia N J Moreno; Juan B Rodriguez
Journal:  ChemMedChem       Date:  2015-04-27       Impact factor: 3.466

6.  Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents.

Authors:  Pablo D Elicio; María N Chao; Melina Galizzi; Catherine Li; Sergio H Szajnman; Roberto Docampo; Silvia N J Moreno; Juan B Rodriguez
Journal:  Eur J Med Chem       Date:  2013-09-18       Impact factor: 6.514

7.  Synthesis and biological evaluation of 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase.

Authors:  Sergio H Szajnman; Guadalupe E García Liñares; Zhu-Hong Li; Cuiying Jiang; Melina Galizzi; Esteban J Bontempi; Marcela Ferella; Silvia N J Moreno; Roberto Docampo; Juan B Rodriguez
Journal:  Bioorg Med Chem       Date:  2007-12-10       Impact factor: 3.641

8.  Fluorine-containing aryloxyethyl thiocyanate derivatives are potent inhibitors of Trypanosoma cruzi and Toxoplasma gondii proliferation.

Authors:  Guadalupe García Liñares; Santiago Gismondi; Nicolás Osa Codesido; Silvia N J Moreno; Roberto Docampo; Juan B Rodriguez
Journal:  Bioorg Med Chem Lett       Date:  2007-07-13       Impact factor: 2.823

9.  In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors, against Trypanosoma cruzi.

Authors:  Julio A Urbina; Juan Luis Concepcion; Aura Caldera; Gilberto Payares; Cristina Sanoja; Takeshi Otomo; Hironobu Hiyoshi
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

10.  Toxoplasma gondii relies on both host and parasite isoprenoids and can be rendered sensitive to atorvastatin.

Authors:  Zhu-Hong Li; Srinivasan Ramakrishnan; Boris Striepen; Silvia N J Moreno
Journal:  PLoS Pathog       Date:  2013-10-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.